您的位置: 首页 > 农业专利 > 详情页

COMBINED THERAPY FOR TREATMENT OF CANCER
专利权人:
ЭПИЗАЙМ; ИНК. (US)
发明人:
КАЙЛЬХАК Хайке (US),НАТСОН Сара Кейтлин (US),КУНТЦ Кевин Уэйн (US)
申请号:
RU2014145552
公开号:
RU2014145552A
申请日:
2013.04.12
申请国别(地区):
RU
年份:
2016
代理人:
摘要:
1. A composition comprising a compound of formula (IIa): or a pharmaceutically acceptable salt thereof and one or more other therapeutic agents, in which each of R and R is independently H or C-C1-6alkyl, optionally substituted with one or more -QT, where Q represents a bond or an unsubstituted or substituted C-C1-6alkyl linker, and T is H, halogen, 4-7 membered heterocycloalkyl, C-C1-6alkyl, OR, COOR, —S (O) R or —NRR, where each of R and R is independently H either C-C1-6alkyl or -QT is oxo; R is isopropyl sulphide and C-C1-6alkyl, C-Cycloalkyl, piperidinyl, tetrahydropyran, tetrahydro-2H-thiopyranyl, cyclopentyl or cyclohexyl, or 4-12 membered heterocycloalkyl, each optionally substituted with one or more -QT, where Q is a bond, C (O) , C (O) NR, NRC (O), S (O), or a C-C1-6alkyl linker, R4 represents H or C-C1-6alkyl, and T4 represents H, halogen, C-C1-6alkyl, hydroxyl, cyano, C-alkoxyl, amino , mono-C-Salkylamino, di-C-Salkylamino, C-Cycloalkyl, C-Saryl, 4-12 membered heterocycloalkyl, 5- or 6 membered heteroaryl or S (O) R, where q is 0, 1 or 2 , and R represents th C-C1-6alkyl, C-Salkenyl, C-C1-6alkynyl, C-Cycloalkyl, C-Saryl, 4-12 membered heterocycloalkyl or 5- or 6 membered heteroaryl, and T is optionally substituted with one or more substituents selected from the group consisting of halogen, C-C1-6alkyl, hydroxyl, cyano, C-Salkoxyl, amino, mono-C-Salkylamino, di-C-Salkylamino, C-Cycloalkyl, C-Saryl, 4-12 membered heterocycloalkyl and 5- or 6-membered heteroaryl except where T is H, halogen, hydroxyl or cyano; or -Q-T is oxo; and R is H, methyl or ethyl. 2. A composition containing any of the compounds listed in table 1 or their pharmaceutically acceptable1. Композиция, содержащая соединение формулы (IIa):или его фармацевтически приемлемые соли и один или более других терапевтических агентов,в которомкаждый из Rи R, независимо, представляет собой H или С-Салкил, необязательно замещенный одним или более -Q-T, где Qпредставляет собой связь или незамещенный и
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充